R
ROIX
vs
S&P 500
S&P 500
Over the past 12 months, ROIX has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +13% growth.
Stocks Performance
ROIX vs S&P 500
Performance Gap
ROIX vs S&P 500
Performance By Year
ROIX vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Response Oncology Inc
Glance View
Response Oncology, Inc. engages in the provision of cancer treatment services through outpatient facilities known as IMPACT centers. The company is headquartered in Memphis, Tennessee and currently employs 10 full-time employees. As of May 20, 2002, the Company had liquidated substantially all of its operating assets and anticipates that the remaining assets will be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, the Company provided advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the non-medical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers.
